Swedish Cancer Institute — Seattle, Washington

Swedish Cancer Institute is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute has participated in 275 clinical trials with 74 currently active.

Therapeutic areas: Metastatic Breast Cancer, Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic.

Sponsors: Pfizer, Celgene, Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute?

Swedish Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute conducted?

Swedish Cancer Institute has 275 clinical trials on record, with 74 currently active. Their work covers Metastatic Breast Cancer, Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic.

Is Swedish Cancer Institute accredited by Crixeo Health?

Yes — Swedish Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Swedish Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.